A phase II study (Biov-121) of clofarabine monotherapy first line in patients aged 65 years or older with acute myeloid leukemia for whom standard intensive chemotherapy is not considered suitable.
- Publication date
- 1 November 2006
- Publisher
- 'American Society of Hematology'
